Literature DB >> 7499268

Isolation of DAP3, a novel mediator of interferon-gamma-induced cell death.

J L Kissil1, L P Deiss, M Bayewitch, T Raveh, G Khaspekov, A Kimchi.   

Abstract

Interaction of certain cytokines with their corresponding cell-surface receptors induces programmed cell death. Interferon-gamma induces in HeLa cells a type of cell death with features characteristic of programmed cell death. Here, we report the isolation of a novel gene, DAP3 (death-associated protein-3), involved in mediating interferon-gamma-induced cell death. The rescue of this gene was performed by a functional selection approach of gene cloning that is based on transfection with an antisense cDNA expression library. The antisense RNA-mediated inactivation of the DAP3 gene protected the cells from interferon-gamma-induced cell death. This property endowed the cells expressing it with a growth advantage in an environment restrictive due to the continuous presence of interferon-gamma and thus provided the basis of its selection. The gene is transcribed into a single 1.7-kilobase mRNA, which is ubiquitously expressed in different tissues and codes for a 46-kDa protein carrying a potential P-loop motif. Ectopic expression of DAP3 in HeLa cells was not compatible with cell growth, resulting in a 16-fold reduction in the number of drug-resistant stable clones. The data presented suggest that DAP3 is a positive mediator of cell death induced by interferon-gamma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499268     DOI: 10.1074/jbc.270.46.27932

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  DAP kinase and DAP-3: novel positive mediators of apoptosis.

Authors:  A Kimchi
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

2.  Identification of genes responsible for osteoblast differentiation from human mesodermal progenitor cells.

Authors:  Huilin Qi; Dean J Aguiar; Shelly M Williams; Alison La Pean; Wei Pan; Catherine M Verfaillie
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-11       Impact factor: 11.205

3.  Novel retroviral vectors to facilitate expression screens in mammalian cells.

Authors:  Eugene Y Koh; Tong Chen; George Q Daley
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

4.  DAP-5, a novel homolog of eukaryotic translation initiation factor 4G isolated as a putative modulator of gamma interferon-induced programmed cell death.

Authors:  N Levy-Strumpf; L P Deiss; H Berissi; A Kimchi
Journal:  Mol Cell Biol       Date:  1997-03       Impact factor: 4.272

5.  DAP-kinase is a Ca2+/calmodulin-dependent, cytoskeletal-associated protein kinase, with cell death-inducing functions that depend on its catalytic activity.

Authors:  O Cohen; E Feinstein; A Kimchi
Journal:  EMBO J       Date:  1997-03-03       Impact factor: 11.598

Review 6.  Mitochondrial ribosomes in cancer.

Authors:  Hyun-Jung Kim; Priyanka Maiti; Antoni Barrientos
Journal:  Semin Cancer Biol       Date:  2017-04-23       Impact factor: 15.707

Review 7.  The effect of IFNgamma on the hepatocyte: cell cycle and apoptosis.

Authors:  B J Tura; K E Bunyan; D J Harrison
Journal:  Int J Exp Pathol       Date:  2001-12       Impact factor: 1.925

8.  Control of Bcl-2 expression by reactive oxygen species.

Authors:  David A Hildeman; Thomas Mitchell; Bruce Aronow; Sara Wojciechowski; John Kappler; Philippa Marrack
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-01       Impact factor: 11.205

9.  Regulation of mitochondrial ribosomal protein S29 (MRPS29) expression by a 5'-upstream open reading frame.

Authors:  Min-Joon Han; Daniel T Chiu; Emine C Koc
Journal:  Mitochondrion       Date:  2010-01-14       Impact factor: 4.160

10.  Death-associated protein 3 is overexpressed in human thyroid oncocytic tumours.

Authors:  C Jacques; J-F Fontaine; B Franc; D Mirebeau-Prunier; S Triau; F Savagner; Y Malthiery
Journal:  Br J Cancer       Date:  2009-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.